GSA Capital Partners’s LENZ Therapeutics LENZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-16,455
Closed -$263K 2232
2025
Q4
$263K Buy
16,455
+4,613
+39% +$134K 0.02% 1243
2025
Q3
$552K Buy
+11,842
New +$435K 0.05% 776
2025
Q1
Sell
-8,385
Closed -$242K 2145
2024
Q4
$242K Sell
8,385
-1,972
-19% -$60.1K 0.02% 1327
2024
Q3
$246K Buy
+10,357
New +$230K 0.02% 1327
2023
Q2
Sell
-5,726
Closed -$98K 2006
2023
Q1
$98K Sell
5,726
-24,916
-81% -$403K 0.01% 1363
2022
Q4
$712K Buy
30,642
+3,399
+12% +$78.8K 0.09% 393
2022
Q3
$605K Buy
27,243
+12,621
+86% +$301K 0.08% 439
2022
Q2
$281K Buy
+14,622
New +$326K 0.04% 866

Other funds holding LENZ